Senior Management DOVs Scientific Advisory Board Arnold S. Lippa, Ph.D. Robert Cancro, M.D. Bernard Beer, Ph.D. Morton E. Goldberg, D.Sc. Phil Skolnick, Ph.D., D.Sc. (hon) Larry Stein, Ph.D. Barbara G. Duncan David H. Farb, Ph.D. J. Robert Horton, Esq. Arvid Carlsson, M.D., Ph.D.     Roger Guillemin, M.D., Ph.D.   DOVs scientific advisory board advises the company with respect to our product development strategy as well as the scientific and business merits of licensing opportunities or acquisition of compounds. The board consists of a group of highly regarded and experienced scientists and clinicians chosen for their particular expertise to advise us on scientific matters affecting the research and development of our drug compounds and the availability of opportunities for collaborations with other pharmaceutical companies. We intend to compensate scientific advisory board members with stock options pursuant to our 2000 stock option plan, and a fee for attendance at meetings. We intend to add additional members to the scientific advisory board.